-
NeuroVive Signs Collaboration Agreement with Karolinska Institutet
americanpharmaceuticalreview
January 11, 2017
NeuroVive Pharmaceutical announced that a collaboration agreement has been signed with Karolinska Institutet, Stockholm, Sweden, regarding development of the company's compound NV556 for the treatment of mitochondrial myopathy.
-
Extend deadline for TB drug regimen: SC
financialexpress
January 11, 2017
The Health Ministry said that it needed time to overhaul the system and that it would also involve moving and training the human resource
-
Ipsen to acquire global oncology assets from Merrimack for $1.25bn
pharmaceutical-technology
January 11, 2017
French pharmaceutical company Ipsen has signed an agreement to acquire global oncology assets from US-based Merrimack Pharmaceuticals for $1.25bn.
-
US FDA accepts Roche’s supplemental biologics licence application
pharmaceutical-technology
January 11, 2017
The US Food and Drug Administration (FDA) has accepted Roche’s supplemental Biologics Licence Application (sBLA) and granted priority review for Tecentriq (atezolizumab) to treat people with locally advanced or metastatic urothelial carcinoma (mUC).
-
Japan’s Takeda to acquire US cancer drug manufacturer ARIAD for $5.2bn
pharmaceutical-technology
January 11, 2017
Japanese-based Takeda Pharmaceutical Company has signed an agreement to acquire American oncology company ARIAD Pharmaceuticals for approximately $5.2bn.
-
Valeant to Sell CeraVe, AcneFree and AMBI Skincare Brands to L'Oreal for $1.3B
americanpharmaceuticalreview
January 11, 2017
Valeant Pharmaceuticals has entered into an agreement to sell its CeraVe, AcneFree and AMBI skincare brands to L'Oréal for $1.3 billion in cash. The CeraVe, AcneFree, and AMBI product lines have annualized revenue of approximately of $168M.
-
MilliporeSigma Expands End-to-End Biodevelopment Centers in North America, China and Europe
americanpharmaceuticalreview
January 11, 2017
MilliporeSigma has announced the expansion of its end-to-end biodevelopment centers to meet increasing customer demand for its turnkey portfolio of bioprocessing products, manufacturing capabilities and industry leading technological expertise.
-
Honeywell Launches ScanPal EDA50hc Mobile Computer for Healthcare Workers
pharmaasia
January 11, 2017
New mobile computer boosts healthcare workers productivity, and enables a better patient-satisfying experience.
-
BioNet received Thai FDA approval of the world’s only available Recombinant Monovalent Acellular Per
pharmaasia
January 11, 2017
BioNet's vaccine is the first recombinant monovalent Pertussis vaccine in the world to receive a MAA for booster indication in adolescents and adults.
-
RedHill Biopharma Announces First Dosing in RHB-105 Supportive PK Studies Ahead of Confirmatory Phas
b3cnewswire
January 11, 2017
The first group of subjects have been dosed in a single-dose three-way crossover pharmacokinetic (PK) study with RHB-105 versus the active comparators in the confirmatory Phase III study and in a food-effect study with RHB-105 in healthy volunteers